111Category: |
Intermediates/Pharmaceutical intermediates |
|
CAS NO: |
8063-07-8 |
EC NO: |
200-411-7 |
Molecular Formula: |
C18H36N4O11 |
Molecular Weight: |
484.4986 |
Specification: |
|
InChI: |
InChI=1/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1 |
Synonyms: |
KANAMYCIN BASE;4))-2-deoxy-y-alpha-d-glucopyranosyl-(;4,6-diamino-2-hydroxy-1,3-cyclohexane3,6¡¯diamino-3,6'-dideoxydi-alpha-d-gluc;4,6-diamino-2-hydroxy-1,3-cyclohexane3,6¡¯diamino-3,6¡¯-dideoxydi-alpha-d-glucos;d-deoxydi;d-streptamine,o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1.fwdarw.6)-o-[6-amin;4,6-diamino-3-[(6-amino-6-deoxyhexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxyhexopyranoside;(1S,2R,3R,4S,6R)-4,6-diamino-3-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside; |
Molecular Structure: |
|